ArticleBritish journal of cancer2012

Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours.

L P Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.